23andMe (ME) Short Interest Ratio & Short Volume $0.50 -0.27 (-35.32%) Closing price 03/28/2025Extended Trading$0.50 0.00 (0.00%) As of 03/28/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock 23andMe Short Interest Data23andMe (ME) has a short interest of 1.79 million shares, representing 11.90% of the float (the number of shares available for trading by the public). This marks a 5.29% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.1, indicating that it would take 4.1 days of the average trading volume of 1.38 million shares to cover all short positions.Current Short Interest1,790,000 sharesPrevious Short Interest1,700,000 sharesChange Vs. Previous Month+5.29%Dollar Volume Sold Short$3.44 millionShort Interest Ratio4.1 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares26,827,000 sharesFloat Size15,040,000 sharesShort Percent of Float11.90%Today's Trading Volume29,282,410 sharesAverage Trading Volume1,376,261 sharesToday's Volume Vs. Average2,128% Short Selling 23andMe? Sign up to receive the latest short interest report for 23andMe and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartME Short Interest Over TimeME Days to Cover Over TimeME Percentage of Float Shorted Over Time 23andMe Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20251,790,000 shares $3.44 million +5.3%11.9%4.1 $1.92 2/28/20251,700,000 shares $3.74 million +22.3%10.7%5.7 $2.20 2/15/20251,390,000 shares $3.54 million +13.9%8.8%5.2 $2.55 1/31/20251,220,000 shares $3.78 million +7.0%7.7%3.9 $3.10 1/15/20251,140,000 shares $3.89 million +4.6%7.1%3.7 $3.41 12/31/20241,090,000 shares $3.54 million +14.5%6.8%3.3 $3.25 12/15/2024951,600 shares $3.19 million +0.2%5.9%2.8 $3.35 11/30/2024950,200 shares $3.37 million -16.7%5.9%2.9 $3.55 11/15/20241,140,000 shares $3.42 million -5.0%7.1%3.9 $3.00 10/31/20241,200,000 shares $5.58 million +16.5%7.9%5.9 $4.65 Get the Latest News and Ratings for ME and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 23andMe and its competitors with MarketBeat's FREE daily newsletter. 10/15/20241,030,000 shares $5.56 million -95.2%6.7%5.5 $5.40 9/30/202421,650,000 shares $7.52 million -6.0%7.3%7.1 $0.35 9/15/202423,040,000 shares $7.83 million +9.3%7.7%6.8 $0.34 8/31/202421,080,000 shares $6.64 million +11.1%7.1%6.4 $0.31 8/15/202418,980,000 shares $6.28 million +29.8%6.3%4.6 $0.33 7/31/202414,620,000 shares $5.85 million +2.7%4.9%3.5 $0.40 7/15/202414,230,000 shares $6.91 million -54.0%4.7%3.3 $0.49 6/30/202430,930,000 shares $12.10 million +10.1%10.9%5.5 $0.39 6/15/202428,090,000 shares $11.13 million -23.4%9.9%5.4 $0.40 5/31/202436,690,000 shares $20.00 million -3.5%12.9%6.3 $0.55 5/15/202438,020,000 shares $22.24 million +5.7%13.7%6.4 $0.59 4/30/202435,960,000 shares $18.06 million +22.3%12.8%5 $0.50 4/15/202429,400,000 shares $11.81 million -10.6%10.5%3.9 $0.40 3/31/202432,880,000 shares $17.49 million +6.2%11.7%4.9 $0.53 3/15/202430,950,000 shares $13.74 million -5.3%11.0%4.4 $0.44 2/29/202432,680,000 shares $18.63 million +5.4%11.7%4.8 $0.57 2/15/202431,010,000 shares $25.10 million +13.6%11.1%4.8 $0.81 1/31/202427,290,000 shares $19.95 million +6.4%9.9%5.1 $0.73 1/15/202425,650,000 shares $18.16 million +4.5%9.3%5.5 $0.71 12/31/202324,550,000 shares $22.43 million -1.6%8.9%5.7 $0.91 12/15/202324,960,000 shares $23.73 million -4.6%9.1%6.2 $0.95 11/30/202326,170,000 shares $22.52 million +2.2%9.5%7.9 $0.86 11/15/202325,600,000 shares $21.35 million -4.8%9.5%7.6 $0.83 10/31/202326,900,000 shares $22.79 million +0.4%9.3%8.3 $0.85 10/15/202326,800,000 shares $22.70 million 0.0%9.3%9.2 $0.85 9/30/202326,810,000 shares $26.21 million +4.2%9.3%9.4 $0.98 9/15/202325,730,000 shares $28.30 million +5.8%8.9%10.4 $1.10 8/31/202324,320,000 shares $26.75 million +3.4%8.3%9 $1.10 8/15/202323,520,000 shares $30.34 million +0.9%8.6%8.8 $1.29 7/31/202323,320,000 shares $44.77 million +2.9%8.6%9.4 $1.92[No Brainer Gold Play]: “Show me a better investment.” (Ad)A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Click here to get Garrett’s Top Four picks now. 7/15/202322,660,000 shares $40.11 million -2.8%8.9%9.6 $1.77 6/30/202323,320,000 shares $40.81 million +4.9%9.2%10.1 $1.75 6/15/202322,230,000 shares $42.01 million -2.5%8.8%9.8 $1.89 5/31/202322,810,000 shares $43.80 million +2.6%9.0%11.2 $1.92 5/15/202322,240,000 shares $44.92 million -1.2%8.9%12.4 $2.02 4/30/202322,500,000 shares $44.33 million +1.9%9.0%12.1 $1.97 4/15/202322,090,000 shares $48.60 million +0.2%8.8%11.6 $2.20 3/31/202322,040,000 shares $50.25 million -1.4%8.8%11 $2.28 3/15/202322,360,000 shares $51.20 million +6.9%9.0%9.8 $2.29 2/28/202320,910,000 shares $52.48 million -2.1%8.4%8.3 $2.51 2/15/202321,350,000 shares $61.27 million +7.0%8.6%8.3 $2.87 1/31/202319,960,000 shares $49.90 million -16.6%8.6%7.4 $2.50 1/15/202323,940,000 shares $57.93 million 0.0%10.3%8.9 $2.42 12/30/202223,950,000 shares $51.73 million +10.2%10.6%8.7 $2.16 12/15/202221,740,000 shares $58.48 million -21.3%9.6%7.7 $2.69 11/30/202227,610,000 shares $84.21 million +6.1%11.4%9 $3.05 11/15/202226,020,000 shares $88.73 million -5.4%11.0%8.2 $3.41 10/31/202227,500,000 shares $86.35 million +13.4%11.3%7.2 $3.14 10/15/202224,260,000 shares $70.84 million -23.1%11.0%6 $2.92 9/30/202231,550,000 shares $90.23 million +17.7%14.3%7.9 $2.86 9/15/202226,810,000 shares $87.67 million +3.6%12.1%6.2 $3.27 8/31/202225,870,000 shares $87.18 million +1.7%11.7%6.2 $3.37 8/15/202225,440,000 shares $117.79 million -21.4%11.7%5.8 $4.63 7/31/202232,360,000 shares $89.96 million -0.5%13.6%8.5 $2.78 7/15/202232,520,000 shares $91.38 million +0.6%13.7%9.1 $2.81 6/30/202232,340,000 shares $80.20 million +9.6%13.8%9.1 $2.48 6/15/202229,510,000 shares $72.89 million -9.8%12.6%8.5 $2.47 5/31/202232,710,000 shares $98.13 million +3.6%14.2%9.2 $3.00 5/15/202231,560,000 shares $89.31 million +3.5%16.6%9.3 $2.83 4/30/202230,490,000 shares $91.17 million +6.2%16.4%9.1 $2.99 4/15/202228,720,000 shares $102.24 million +3.9%15.4%8.5 $3.56 3/31/202227,650,000 shares $105.90 million +46.8%14.8%7.9 $3.83 3/15/202218,840,000 shares $65.00 million +36.8%10.1%5 $3.45 2/28/202213,770,000 shares $61.55 million -0.1%8.2%4.5 $4.47 2/15/202213,780,000 shares $64.90 million -5.2%8.2%4.6 $4.71 1/31/202214,530,000 shares $67.86 million +15.0%13.9%4.9 $4.67 1/15/202212,630,000 shares $65.42 million -7.3%12.3%4.2 $5.18 12/31/202113,630,000 shares $90.78 million +11.1%13.3%4.2 $6.66 12/15/202112,270,000 shares $93.25 million +2.9%12.0%4 $7.60 11/30/202111,930,000 shares $98.06 million +11.2%12.5%4.4 $8.22 11/15/202110,730,000 shares $119.85 million -8.8%11.2%4.3 $11.17 10/29/202111,770,000 shares $136.41 million +3.9%20.4%4.7 $11.59 10/15/202111,330,000 shares $104.35 million +38.5%19.3%4.9 $9.21 9/30/20218,180,000 shares $74.11 million +8.2%13.9%4.8 $9.06 9/15/20217,560,000 shares $61.08 million -2.0%12.8%4.5 $8.08 8/31/20217,710,000 shares $66.31 million +10.6%13.1%3.8 $8.60 8/13/20216,970,000 shares $52.97 million No Change11.8%3.4 $7.60 ME Short Interest - Frequently Asked Questions What is 23andMe's current short interest? Short interest is the volume of 23andMe shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 1,790,000 shares of ME short. 11.90% of 23andMe's shares are currently sold short. Learn More on 23andMe's current short interest. What is a good short interest ratio for 23andMe? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ME shares currently have a short interest ratio of 4.0. Learn More on 23andMe's short interest ratio. Which institutional investors are shorting 23andMe? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of 23andMe: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for 23andMe? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.90% of 23andMe's floating shares are currently sold short. Is 23andMe's short interest increasing or decreasing? 23andMe saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 1,790,000 shares, an increase of 5.3% from the previous total of 1,700,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is 23andMe's float size? 23andMe currently has issued a total of 26,827,000 shares. Some of 23andMe's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 23andMe currently has a public float of 15,040,000 shares. How does 23andMe's short interest compare to its competitors? 11.90% of 23andMe's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 23andMe: Context Therapeutics Inc. (3.85%), RenovoRx, Inc. (0.49%), Annovis Bio, Inc. (21.89%), Prelude Therapeutics Incorporated (3.88%), Adverum Biotechnologies, Inc. (14.03%), Actinium Pharmaceuticals, Inc. (6.58%), Applied Therapeutics, Inc. (16.93%), Shattuck Labs, Inc. (4.16%), Verrica Pharmaceuticals Inc. (8.67%), Renovaro Inc. (5.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), Strategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short 23andMe stock? Short selling ME is an investing strategy that aims to generate trading profit from 23andMe as its price is falling. ME shares are trading down $0.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 23andMe? A short squeeze for 23andMe occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ME, which in turn drives the price of the stock up even further. How often is 23andMe's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ME, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Context Therapeutics Short Interest Data RenovoRx Short Interest Data Annovis Bio Short Interest Data Prelude Therapeutics Short Interest Data Adverum Biotechnologies Short Interest Data Actinium Pharmaceuticals Short Interest Data Applied Therapeutics Short Interest Data Shattuck Labs Short Interest Data Verrica Pharmaceuticals Short Interest Data Renovaro Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ME) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 23andMe Holding Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share 23andMe With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.